These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15111238)

  • 1. Chronic memantine does not block 3-nitropropionic acid-delayed ischaemic tolerance in rat hippocampal slices ex vivo.
    Frankiewicz T; Parsons CG
    Neurotox Res; 2004; 5(8):617-22. PubMed ID: 15111238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Nitropropionic acid induces ischemic tolerance in gerbil hippocampus in vivo.
    Sugino T; Nozaki K; Takagi Y; Hashimoto N
    Neurosci Lett; 1999 Jan; 259(1):9-12. PubMed ID: 10027543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of NMDA-receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slices.
    Frankiewicz T; Pilc A; Parsons CG
    Neuropharmacology; 2000 Feb; 39(4):631-42. PubMed ID: 10728884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
    Volbracht C; van Beek J; Zhu C; Blomgren K; Leist M
    Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of hypoxic tolerance in rat hippocampal slices following 3-nitropropionic acid is not mediated by endogenous nerve growth factor.
    Riepe MW; Kasischke K; Gericke CA; Löwe A; Hellweg R
    Neurosci Lett; 1996 Jun; 211(1):9-12. PubMed ID: 8809835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices.
    Frankiewicz T; Potier B; Bashir ZI; Collingridge GL; Parsons CG
    Br J Pharmacol; 1996 Feb; 117(4):689-97. PubMed ID: 8646415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptations of NMDA and dopamine D2, but not of muscarinic receptors following 14 days administration of uncompetitive NMDA receptor antagonists.
    Hesselink MB; De Boer AG; Breimer DD; Danysz W
    J Neural Transm (Vienna); 1999; 106(5-6):409-21. PubMed ID: 10443547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA receptor antagonism does not inhibit induction of ischemic tolerance in gerbil brain in vivo.
    Duszczyk M; Gadamski R; Ziembowicz A; Danysz W; Lazarewicz JW
    Neurotox Res; 2005; 7(4):283-92. PubMed ID: 16179265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid.
    Tozzi A; Costa C; Di Filippo M; Tantucci M; Siliquini S; Belcastro V; Parnetti L; Picconi B; Calabresi P
    Exp Neurol; 2007 Oct; 207(2):218-26. PubMed ID: 17673201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
    Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA
    Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation.
    Chen HS; Wang YF; Rayudu PV; Edgecomb P; Neill JC; Segal MM; Lipton SA; Jensen FE
    Neuroscience; 1998 Oct; 86(4):1121-32. PubMed ID: 9697119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy.
    Lee WT; Shen YZ; Chang C
    Neuroscience; 2000; 95(1):89-95. PubMed ID: 10619465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced LTP in aged rats: Detrimental or compensatory?
    Pinho J; Vale R; Batalha VL; Costenla AR; Dias R; Rombo D; Sebastião AM; de Mendonça A; Diógenes MJ
    Neuropharmacology; 2017 Mar; 114():12-19. PubMed ID: 27889488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical preconditioning prevents paradoxical increase in glutamate release during ischemia by activating ATP-dependent potassium channels in gerbil hippocampus.
    Nakagawa I; Ogawa Y; Noriyama Y; Nakase H; Yamashita M; Sakaki T
    Exp Neurol; 2003 Sep; 183(1):180-7. PubMed ID: 12957501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Learning deficits induced by chronic intraventricular infusion of quinolinic acid--protection by MK-801 and memantine.
    Misztal M; Frankiewicz T; Parsons CG; Danysz W
    Eur J Pharmacol; 1996 Jan; 296(1):1-8. PubMed ID: 8720470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus.
    Bond A; Lodge D; Hicks CA; Ward MA; O'Neill MJ
    Eur J Pharmacol; 1999 Sep; 380(2-3):91-9. PubMed ID: 10513567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.
    Nakamura S; Murayama N; Noshita T; Katsuragi R; Ohno T
    Eur J Pharmacol; 2006 Oct; 548(1-3):115-22. PubMed ID: 16952349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration.
    Hesselink MB; Smolders H; De Boer AG; Breimer DD; Danysz W
    Behav Pharmacol; 1999 Feb; 10(1):85-98. PubMed ID: 10780305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing conditions significantly attenuate the neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro.
    Pringle AK; Self J; Eshak M; Iannotti F
    Eur J Neurosci; 2000 Nov; 12(11):3833-42. PubMed ID: 11069578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.